Meprednisone - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for meprednisone and what is the scope of freedom to operate?
Meprednisone
is the generic ingredient in one branded drug marketed by Schering and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for meprednisone
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 1 |
Patent Applications: | 6,272 |
DailyMed Link: | meprednisone at DailyMed |
Recent Clinical Trials for meprednisone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shengjing Hospital | Phase 1/Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for meprednisone
US Patents and Regulatory Information for meprednisone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | BETAPAR | meprednisone | TABLET;ORAL | 016053-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |